{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:08:22Z","timestamp":1772640502047,"version":"3.50.1"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Although the risk of breast cancer increases with advancing age, some regions have larger number of young breast cancer patients (\u226445\u00a0years-old), such as the Middle East, Eastern Asia, and North Africa, with more aggressive and poorly differentiated tumors. We aimed to conduct an <jats:italic>in-silico<\/jats:italic> analysis in an attempt to understand the aggressive nature of early-onset breast cancer, and to identify potential drivers of early-onset breast cancer using gene expression profiling datasets in a population-dependent manner.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Functional genomics experiments data were acquired from cBioPortal database for cancer genomics, followed by the stratification of patients based on the age at representation of breast cancer and race. Differential gene expression analysis and gene amplification status analysis were carried out, followed by hub gene, transcription factor, and signalling pathway identification.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> PAM50 subtype analysis revealed that young patients (\u226445\u00a0years-old) had four-fold more basal tumors and worst progression-free survival (median of 101\u00a0months), compared with the 45\u201365\u00a0years group (median of 168\u00a0months). Fourteen genes were amplified in more than 14% of patients with an early-onset breast cancer. Interestingly, FREM2, LINC00332, and LINC00366 were exclusively amplified in younger patients. Gene expression data from three different populations (Asian, White, and African) revealed a unique transcriptomic profile of young patients, which was also reflected on the PAM50 subtype analysis. Our data indicates a higher tendency of young African patients to develop basal tumors, while young Asian patients are more prone to developing Luminal A tumors. Most genes that were found to be upregulated in younger patients are involved in important signaling pathways that promote cancer progression and metastasis, such as MAPK pathway, Reelin pathway and the PI3K\/Akt pathway.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study provides strong evidence that the molecular profile of tumors derived from young breast cancer patients of different populations is unique and may explain the aggressiveness of these tumors, stressing the need to conduct population- based multi-omic analyses to identify the potential drivers for tumorigenesis and molecular profiles of young breast cancer patients.<\/jats:p>","DOI":"10.3389\/fgene.2022.1039037","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T06:28:13Z","timestamp":1672813693000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women"],"prefix":"10.3389","volume":"13","author":[{"given":"Marah","family":"Tabbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood Y.","family":"Hachim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem Kais","family":"Jan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Adrian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000477895","article-title":"Prognostic significance of focal adhesion kinase in node-negative breast cancer","volume":"12","author":"Almstedt","year":"2017","journal-title":"Breast Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fnmol.2017.00199","article-title":"Distinct features of Doublecortin as a marker of neuronal migration and its implications in Cancer cell mobility","volume":"10","author":"Ayanlaja","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/jco.2015.33.15_suppl.579","article-title":"The pattern of somatic mutations and chromosomal copy number variations (CNV) in young breast cancer (BC) patients (pts)","volume":"33","author":"Azim","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1002\/jcp.22620","article-title":"Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer","volume":"226","author":"Baillo","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1158\/1538-7445.am2017-1975","article-title":"Abstract 1975: FAM83B: A novel regulator of cell plasticity in breast cancer","volume":"77","author":"Bartel","year":"2017","journal-title":"Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0154325","DOI":"10.1371\/journal.pone.0154325","article-title":"A set of miRNAs, their gene and protein targets and stromal genes distinguish early from late onset ER positive breast cancer","volume":"11","author":"Bastos","year":"2016","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1101\/gad.1024602","article-title":"c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression","volume":"16","author":"Baudino","year":"2002","journal-title":"Genes Dev."},{"key":"B8","unstructured":"SEER Cancer Stat Facts: Female Breast CancerBethesda, MDNational Cancer Institute"},{"key":"B9","unstructured":"Cancer incidence in United Arab Emirates annual report of the UAE national cancer registry- 2017 www.mohap.gov.ae Statistics and research canter2017"},{"key":"B11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1200\/OP.20.00793","article-title":"Breast cancer in adolescent and young adult women under the age of 40 years","volume":"17","author":"Cathcart-Rake","year":"2021","journal-title":"JCO Oncol. Pract."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s11033-016-4061-4","article-title":"Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey","volume":"43","author":"Cecener","year":"2016","journal-title":"Mol. Biol. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1097\/AOG.0000000000003889","article-title":"Executive summary of the early-onset breast cancer evidence review conference","volume":"135","author":"Chelmow","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"956869","DOI":"10.3389\/fgene.2022.956869","article-title":"High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"646409","DOI":"10.3389\/fonc.2021.646409","article-title":"A signature of nine lncRNA methylated genes predicts survival in patients with glioma","volume":"11","author":"Cheng","year":"2021","journal-title":"Front. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"12828","DOI":"10.3390\/ijms222312828","article-title":"The role of Ereg\/EGFR pathway in tumor progression","volume":"22","author":"Cheng","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1016\/S1470-2045(13)70165-7","article-title":"Breast cancer in Arab populations: Molecular characteristics and disease management implications","volume":"14","author":"Chouchane","year":"2013","journal-title":"Lancet. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s41598-020-77636-4","article-title":"Investigation of MicroRNA and transcription factor mediated regulatory network for silicosis using systems biology approach","volume":"11","author":"Choudhari","year":"2021","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e63204","DOI":"10.1371\/journal.pone.0063204","article-title":"Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women","volume":"8","author":"Colak","year":"2013","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10549-011-1872-9","article-title":"Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer","volume":"131","author":"Collins","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"B21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bbrc.2020.03.095","article-title":"PSMD12 promotes breast cancer growth via inhibiting the expression of pro-apoptotic genes","volume":"526","author":"Du","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcdb.2016.08.025","article-title":"Molecular heterogeneity in breast cancer: State of the science and implications for patient care","volume":"64","author":"Ellsworth","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1200\/jco.2008.26.15_suppl.1022","article-title":"Identification of a gene expression breast cancer nodal metastasis profile","volume":"26","author":"Ellsworth","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"22460","DOI":"10.18632\/oncotarget.25123","article-title":"Somatic mutations in early-onset luminal breast cancer","volume":"9","author":"Encinas","year":"2018","journal-title":"Oncotarget"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/s1357-2725(02)00052-3","article-title":"Age-associated biomarker profiles of human breast cancer","volume":"34","author":"Eppenberger-Castori","year":"2002","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"100128","DOI":"10.1016\/j.xcrm.2020.100128","article-title":"The clinical kinase index: A method to prioritize understudied kinases as drug targets for the treatment of cancer","volume":"1","author":"Essegian","year":"2020","journal-title":"Cell Rep. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/bcr1828","article-title":"Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women","volume":"9","author":"Foulkes","year":"2007","journal-title":"Breast Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/cbf.3426","article-title":"Igsf1: A novel oncogene regulates the thyroid cancer progression","volume":"37","author":"Guan","year":"2019","journal-title":"Cell biochem. Funct."},{"key":"B29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ccell.2016.02.013","article-title":"PITPNC1 recruits RAB1B to the Golgi network to drive malignant secretion","volume":"29","author":"Halberg","year":"2016","journal-title":"Cancer Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"eaap7777","DOI":"10.1126\/sciadv.aap7777","article-title":"Nucleolar integrity during interphase supports faithful Cdk1 activation and mitotic entry","volume":"4","author":"Hayashi","year":"2018","journal-title":"Sci. Adv."},{"key":"B31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12916-022-02260-0","article-title":"The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology","volume":"20","author":"Hirko","year":"2022","journal-title":"BMC Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0187638","DOI":"10.1371\/journal.pone.0187638","article-title":"A tissue microRNA signature that predicts the prognosis of breast cancer in young women","volume":"12","author":"Hironaka-Mitsuhashi","year":"2017","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.4049\/jimmunol.1102843","article-title":"Anti\u2013il-20 monoclonal antibody suppresses breast cancer progression and bone osteolysis in murine models","volume":"188","author":"Hsu","year":"2012","journal-title":"J. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1038\/s41467-021-26505-3","article-title":"Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes","volume":"12","author":"Jindal","year":"2021","journal-title":"Nat. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"13688","DOI":"10.18632\/oncotarget.4051","article-title":"Gene expression in \u201cyoung adult type\u201d breast cancer: A retrospective analysis","volume":"6","author":"Johnson","year":"2015","journal-title":"Oncotarget"},{"key":"B37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13058-020-01363-x","article-title":"Extracellular vesicles from young women\u2019s breast cancer patients drive increased invasion of non-malignant cells via the focal adhesion kinase pathway: A proteomic approach","volume":"22","author":"Jordan","year":"2020","journal-title":"Breast Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41467-017-01775-y","article-title":"Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women","volume":"8","author":"Kadalayil","year":"2017","journal-title":"Nat. Commun."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4172\/2376-0281.1000322","article-title":"Breast cancer with beh\u00e7\u2019s disease: A short review","volume":"5","author":"Kanazawa","year":"2018","journal-title":"Int. J. Neurorehabil."},{"key":"B40","doi-asserted-by":"publisher","first-page":"102646","DOI":"10.1016\/j.ebiom.2020.102646","article-title":"Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis","volume":"52","author":"Kanwar","year":"2020","journal-title":"EBioMedicine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.2174\/1381612824666180926095709","article-title":"Role of p53 gene in breast cancer: Focus on mutation spectrum and therapeutic strategies","volume":"24","author":"Kaur","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1038\/s41467-019-11020-3","article-title":"Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes","volume":"10","author":"Koedoot","year":"2019","journal-title":"Nat. Commun."},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071726","volume-title":"Is carboxypeptidase B1 a prognostic marker for ductal carcinoma","author":"Kothari","year":"2021"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/jcb.29886","article-title":"Prognostic significance of hedgehog signaling network-related gene expression in breast cancer patients","volume":"122","author":"Kuehn","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.cellsig.2016.08.006","article-title":"STAT3-induced WDR1 overexpression promotes breast cancer cell migration","volume":"28","author":"Lee","year":"2016","journal-title":"Cell. Signal."},{"key":"B47","first-page":"101963","article-title":"Mir-4719 inhibits migration and invasion of human breast cancer cells via targeting ARHGAP36","volume":"43","author":"Li","year":"2021","journal-title":"J. South. Med. Univ."},{"key":"B48","doi-asserted-by":"publisher","first-page":"101963","DOI":"10.1016\/j.redox.2021.101963","article-title":"LRRC17 controls BMSC senescence via mitophagy and inhibits the therapeutic effect of bmscs on ovariectomy-induced bone loss","volume":"43","author":"Liu","year":"2021","journal-title":"Redox Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/mc.23310","article-title":"miR-506-loaded gelatin nanospheres target PENK and inactivate the ERK\/Fos signaling pathway to suppress triple-negative breast cancer aggressiveness","volume":"60","author":"Liu","year":"2021","journal-title":"Mol. Carcinog."},{"key":"B50","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3892\/etm.2018.7028","article-title":"TBX2 overexpression promotes proliferation and invasion through epithelial-mesenchymal transition and ERK signaling pathway","volume":"17","author":"Liu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/tox.23495","article-title":"ABCA8 inhibits breast cancer cell proliferation by regulating the AMP activated protein kinase\/mammalian target of rapamycin signaling pathway","volume":"37","author":"Lv","year":"2022","journal-title":"Environ. Toxicol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ncb2024","article-title":"miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis","volume":"12","author":"Ma","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13148-022-01239-1","article-title":"Aberrant epigenetic and transcriptional events associated with breast cancer risk","volume":"14","author":"Marino","year":"2022","journal-title":"Clin. Epigenetics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00428-013-1468-3","article-title":"Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer","volume":"463","author":"McCart Reed","year":"2013","journal-title":"Virchows Arch."},{"key":"B55","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10689-012-9557-z","article-title":"Routine TP53 testing for breast cancer under age 30: Ready for prime time?","volume":"11","author":"McCuaig","year":"2012","journal-title":"Fam. Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"a001677","DOI":"10.1101\/mcs.a001677","article-title":"Metastatic triple-negative breast cancer patient with tp53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events","volume":"3","author":"Mei\u00dfner","year":"2017","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"B57","doi-asserted-by":"publisher","first-page":"463","DOI":"10.4149\/BLL_2018_085","article-title":"Epidemiology of gliomas in women diagnosed with breast cancer supports the protective role of estrogenic exposure","volume":"119","author":"Mezencev","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.3390\/cancers12082089","article-title":"Comprehensive cohort analysis of mutational spectrum in early-onset breast cancer patients","volume":"12","author":"Midha","year":"2020","journal-title":"Cancers"},{"key":"B59","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ijsu.2010.05.012","article-title":"Age at diagnosis of breast cancer in Arab nations","volume":"8","author":"Najjar","year":"2010","journal-title":"Int. J. Surg."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s40265-020-01394-w","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in hormone- positive breast cancer","volume":"80","author":"Nunnery","year":"2020","journal-title":"Drugs"},{"key":"B61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s10038-020-00849-y","article-title":"The relationship between BRCA-associated breast cancer and age factors: An analysis of the Japanese HBOC consortium database","volume":"66","author":"Okano","year":"2021","journal-title":"J. Hum. Genet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1158\/0008-5472.CAN-10-3738","article-title":"Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer","volume":"71","author":"O\u2019Toole","year":"2011","journal-title":"Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1758834014530023","article-title":"The PI3K\/AKT\/mTOR pathway in breast cancer: Targets, trials and biomarkers","volume":"6","author":"Paplomata","year":"2014","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"a003293","DOI":"10.1101\/cshperspect.a003293","article-title":"Systems biology and genomics of breast cancer","volume":"3","author":"Perou","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.1158\/0008-5472.CAN-15-0709","article-title":"Amphiregulin is a critical downstream effector of estrogen signaling in ER\u0391-positive breast cancer","volume":"75","author":"Peterson","year":"2015","journal-title":"Cancer Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12885-017-3827-y","article-title":"Protein kinase C \u03b1 enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin","volume":"17","author":"Pham","year":"2017","journal-title":"BMC Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1158\/1078-0432.CCR-16-2656","article-title":"Enrichment of PI3K-AKT-mTOR pathway activation in hepatic metastases from breast cancer","volume":"23","author":"Pierobon","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"21444","DOI":"10.18632\/oncotarget.15590","article-title":"PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast","volume":"8","author":"Qian","year":"2017","journal-title":"Oncotarget"},{"key":"B69","doi-asserted-by":"publisher","first-page":"45305","DOI":"10.1038\/srep45305","article-title":"Extracellular matrix protein Reelin promotes myeloma progression by facilitating tumor cell proliferation and glycolysis","volume":"7","author":"Qin","year":"2017","journal-title":"Sci. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10549-005-9017-7","article-title":"The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours","volume":"95","author":"Rauta","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/j.clbc.2019.08.008","article-title":"The role of CXCL13 and CXCL9 in early breast cancer","volume":"20","author":"Razis","year":"2020","journal-title":"Clin. Breast Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12964-017-0213-y","article-title":"Involvement of hedgehog pathway in early-onset, aggressive molecular subtypes and metastatic potential of breast cancer","volume":"16","author":"Riaz","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e35667","DOI":"10.1371\/journal.pone.0035667","article-title":"Angiotensin II facilitates breast cancer cell migration and metastasis","volume":"7","author":"Rodrigues-Ferreira","year":"2012","journal-title":"PLoS One"},{"key":"B74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: Different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1186\/bcr2796","article-title":"A PALB2 mutation associated with high risk of breast cancer","volume":"12","author":"Southey","year":"2010","journal-title":"Breast Cancer Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12935-019-0986-8","article-title":"Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer","volume":"19","author":"Sun","year":"2019","journal-title":"Cancer Cell Int."},{"key":"B77","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca. Cancer J. Clin."},{"key":"B78","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ccell.2018.05.001","article-title":"Cancer cells co-opt the neuronal redox-sensing channel TRPA1 to promote oxidative-stress tolerance","volume":"33","author":"Takahashi","year":"2018","journal-title":"Cancer Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"46589","DOI":"10.18632\/oncotarget.10306","article-title":"ART3 regulates triple-negative breast cancer cell function via activation of Akt and ERK pathways","volume":"7","author":"Tan","year":"2016","journal-title":"Oncotarget"},{"key":"B80","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1186\/bcr3392","article-title":"Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families","volume":"15","author":"Teo","year":"2013","journal-title":"Breast Cancer Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12032-022-01877-8","article-title":"Molecular characterization of early breast cancer onset to understand disease phenotypes in African patients","volume":"40","author":"Tonouo","year":"2022","journal-title":"Med. Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e56761","DOI":"10.1371\/journal.pone.0056761","article-title":"Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress","volume":"8","author":"Triulzi","year":"2013","journal-title":"PLOS ONE"},{"key":"B83","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fmed.2017.00227","article-title":"Tumor heterogeneity in breast cancer","volume":"4","author":"Turashvili","year":"2017","journal-title":"Front. Med."},{"key":"B84","first-page":"2148","article-title":"Breast cancer metastases are molecularly distinct from their primary tumors","volume":"27","author":"Vecchi","year":"2007","journal-title":"Nat. News"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3390\/ijms18102111","article-title":"PARP1 in carcinomas and PARP1 inhibitors as antineoplastic drugs","volume":"18","author":"Wang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2174\/0929867321666141106124315","article-title":"Targeting the NF\u03baB signaling pathways for breast cancer prevention and therapy","volume":"22","author":"Wang","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"555865","DOI":"10.3389\/fgene.2020.555865","article-title":"Identification of tumor microenvironment-related prognostic biomarkers in luminal breast cancer","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Genet."},{"key":"B88","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"Warren","year":"2019","journal-title":"Cell Death Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5114\/wo.2014.47037","article-title":"Overexpression of raf-1 in basal-like carcinoma of the breast: Correlation with clinicopathology and prognosis","volume":"18","author":"Wu","year":"2014","journal-title":"Contemp. Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/bcr1765","article-title":"Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers","volume":"9","author":"Yau","year":"2007","journal-title":"Breast Cancer Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10549-011-1345-1","article-title":"Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers","volume":"126","author":"Yau","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"B92","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","article-title":"PALB2 links BRCA1 and BRCA2 in the DNA-damage response","volume":"19","author":"Zhang","year":"2009","journal-title":"Curr. Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-020-02696-z","article-title":"Transcriptomic analysis identifies organ-specific metastasis genes and pathways across different primary sites","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Transl. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.2147\/OTT.S242406","article-title":"The expression and prognostic significance of claudin-8 and androgen receptor in breast cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"B95","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s10020-020-00158-2","article-title":"TFPI2 suppresses breast cancer progression through inhibiting twist-integrin \u03b15 pathway","volume":"26","author":"Zhao","year":"2020","journal-title":"Mol. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.3390\/cancers13164117","article-title":"Algorithmically deduced FREM2 molecular pathway is a potent grade and survival biomarker of human gliomas","volume":"13","author":"Zolotovskaia","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1039037\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T06:28:22Z","timestamp":1672813702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1039037\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":94,"alternative-id":["10.3389\/fgene.2022.1039037"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.1039037","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1039037"}}